5 completed. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow RO4602522: new trials by email Literature Review of RO4602522 trials Research Report on RO4602522
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 2-Part Study to Evaluate the Safety of Supra-Therapeutic Doses of RO4602522 and to Investigate the Effect of RO4602522 on the QTc Interval Placebo RO4602522, RO4602522, moxifloxacin - Healthy Volunteer | Phase 1 | Completed | Hoffmann-La Roche | 203 | 2014-04-01 | 2016-11-02 |
| A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy RO4602522, Placebo, Donepezil - Alzheimer's Disease | Phase 2 | Completed | Hoffmann-La Roche | 542 | 2012-10-24 | 2017-05-30 |
| A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers 11C-L-deprenyl-D2, RO4602522 - Healthy Volunteer, Alzheimer's Disease | Phase 1 | Completed | Hoffmann-La Roche | 17 | 2012-09-01 | 2016-11-02 |
| A Study of The Effects of Multiple Doses of Ketoconazole on Single Dose Pharmacokinetics of RO4602522 in Healthy Male Volunteers RO4602522, ketoconazole - Healthy Volunteer | Phase 1 | Completed | Hoffmann-La Roche | 34 | 2012-07-01 | 2016-11-02 |
| A Single Dose Study of Radiolabeled RO4602522 in Healthy Volunteers RO4602522 - Healthy Volunteer | Phase 1 | Completed | Hoffmann-La Roche | 6 | 2012-06-01 | 2016-11-02 |
Netherlands (2) · Sweden (2) · United States (2) · Australia (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · South Korea (1) · Spain (1) · United Kingdom (1)